rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Akinbolade Oyegunwa

EVP, CIO & CTO

Company insider

Files Form 4 as: EVP, CIO & CTO, Labcorp Holdings.

In numbers

Trades disclosed
45
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
1 Nov 2024
Last trade
1 Sep 2026
Last filed
3 Sep 2026

Companies traded

Where they are an officer
LH Labcorp HoldingsOfficer · Diagnostics & Labs · last 1 Sep 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
1 Sep 2026filed 3 Sep 2026LH Labcorp Holdingsoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—750 at $0.00filing
1 Sep 2026filed 3 Sep 2026LH Labcorp Holdingsoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—750 at $0.00filing
26 Mar 2026filed 30 Mar 2026LH Labcorp HoldingsDiagnostics & LabsSEC FORM 4 Code A—1,340 at $0.00filing
26 Mar 2026filed 30 Mar 2026LH Labcorp HoldingsDiagnostics & LabsSEC FORM 4 Code F$103K382 at $268.38filing
26 Mar 2026filed 30 Mar 2026LH Labcorp HoldingsDiagnostics & LabsSEC FORM 4 Code A—1,340 at $0.00filing
26 Mar 2026filed 30 Mar 2026LH Labcorp HoldingsDiagnostics & LabsSEC FORM 4 Code F$103K382 at $268.38filing
11 Feb 2026filed 13 Feb 2026LH Labcorp HoldingsDiagnostics & LabsSEC FORM 4 Code M—230filing
11 Feb 2026filed 13 Feb 2026LH Labcorp HoldingsDiagnostics & LabsSEC FORM 4 Code F$20K68 at $289.89filing
11 Feb 2026filed 13 Feb 2026LH Labcorp Holdingsoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—230 at $0.00filing
11 Feb 2026filed 13 Feb 2026LH Labcorp Holdingsoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—230 at $0.00filing
11 Feb 2026filed 13 Feb 2026LH Labcorp HoldingsDiagnostics & LabsSEC FORM 4 Code M—230filing
11 Feb 2026filed 13 Feb 2026LH Labcorp HoldingsDiagnostics & LabsSEC FORM 4 Code F$20K68 at $289.89filing
10 Feb 2026filed 12 Feb 2026LH Labcorp Holdingsoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—2,400 at $0.00filing
10 Feb 2026filed 12 Feb 2026LH Labcorp Holdingsoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—810 at $0.00filing
10 Feb 2026filed 12 Feb 2026LH Labcorp Holdingsoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—2,400 at $0.00filing
10 Feb 2026filed 12 Feb 2026LH Labcorp Holdingsoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—810 at $0.00filing
9 Feb 2026filed 10 Feb 2026LH Labcorp HoldingsDiagnostics & LabsSEC FORM 4 Code F$14K51 at $274.01filing
9 Feb 2026filed 10 Feb 2026LH Labcorp HoldingsDiagnostics & LabsSEC FORM 4 Code F$14K51 at $274.01filing
7 Feb 2026filed 10 Feb 2026LH Labcorp HoldingsDiagnostics & LabsSEC FORM 4 Code M—149filing
7 Feb 2026filed 10 Feb 2026LH Labcorp Holdingsoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—149 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Bryan T. VaughnEVP and President, Diagnostics · EVP and President, Diagnostics at Labcorp Holdings, filing Form 4 there in the last year
Brian J. CaveneyEVP, Pres of BLS, CMO & CSO · EVP, Pres of BLS, CMO & CSO at Labcorp Holdings, filing Form 4 there in the last year
Jonathan C. MeltzerEVP, COO · EVP, COO at Labcorp Holdings, filing Form 4 there in the last year
Kerrii B. AndersonDirector · Director at Labcorp Holdings, filing Form 4 there in the last year
Adam H. SchechterDirector · President & CEO at Labcorp Holdings, filing Form 4 there in the last year